Clinical characteristics, treatment patterns and relapse in patients with clinical stage IS testicular cancer

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study

(2019) Klaus-Peter Dieckmann et al.   JOURNAL OF CLINICAL ONCOLOGY

Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment

(2019) Klaus-Peter Dieckmann et al.   Biomed Research International

Treatment and Outcome of Patients with Stage IS Testicular Cancer: A Retrospective Study from the Spanish Germ Cell Cancer Group

(2019) J. Aparicio et al.   JOURNAL OF UROLOGY

Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

(2019) Timothy Gilligan et al.   Journal of the National Comprehensive Cancer Network

Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer

(2018) Sophia C. Kamran et al.   EUROPEAN UROLOGY

Pure Testicular Seminoma with Non-Pathologic Elevation of Alpha Fetoprotein: A Case Series

(2017) Klaus-Peter Dieckmann et al.   UROLOGIA INTERNATIONALIS

Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)

(2016) T. Tandstad et al.   ANNALS OF ONCOLOGY

Lactate dehydrogenase 5: An old friend and a new hope in the war on cancer

(2015) Katarzyna Augoff et al.   CANCER LETTERS

Guidelines on Testicular Cancer: 2015 Update

(2015) Peter Albers et al.   EUROPEAN UROLOGY

Patterns of Relapse in Patients With Clinical Stage I Testicular Cancer Managed With Active Surveillance

(2015) Christian Kollmannsberger et al.   JOURNAL OF CLINICAL ONCOLOGY

Outcomes and treatment patterns as a function of time in stage IS testicular seminoma: A population-based analysis

(2014) Kamran A. Ahmed et al.   Cancer Epidemiology

Validation of Surveillance, Epidemiology, and End Results TNM staging for testicular germ cell tumor

(2014) Kenneth D. Faber et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Variations in Normal Serum Alpha-Fetoprotein (AFP) Levels in Patients with Testicular Cancer on Surveillance

(2012) Priti Patel et al.   ONKOLOGIE

Lactate dehydrogenase production in hepatocytes is increased at an early stage of acute liver failure

(2011) KAZUHIRO KOTOH et al.   Experimental and Therapeutic Medicine

Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study

(2010) T. Tandstad et al.   ANNALS OF ONCOLOGY

Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program

(2009) Torgrim Tandstad et al.   JOURNAL OF CLINICAL ONCOLOGY

The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor

(2008) Atreya Dash et al.   CANCER